Back

iRhythm upsizes IPO launch by raising $107M to support its Zio heart monitor

FierceBiotech

The maker of the Zio wearable heart monitor, iRhythm Technologies, upsized its initial public offering, raising $107 million compared to the $86 million it originally sought to gear up for the commercial and clinical reach of its device.

Shares of the San Francisco-based company begin trading today on the NASDAQ under the ticker “IRTC”, the company said. Bookrunners for the offering are JP Morgan and Morgan Stanley. Canaccord Genuity and BTIG are acting as co-managers.

The offering is expected to close on October 25.

Read More

CONTACT US FOR MORE INFORMATION